Navigation Links
Synosia Therapeutics Announces Appointment of Chief Business Officer
Date:12/13/2007

SAN FRANCISCO, December 13 /PRNewswire/ -- Synosia Therapeutics today announced the appointment of Antony Blanc, Ph.D., as the company's new chief business officer, effective immediately.

Dr Blanc, who will serve as head of Synosia's office in Basel, Switzerland, joins from Syngenta, where he created and led the biopharmaceuticals business unit. A molecular biologist by training and an experienced biotech entrepreneur, Dr. Blanc helped biotech and pharma clients with R&D, commercial and strategy issues as associate partner with the business consultants McKinsey & Company.

"With a strong entrepreneurial flair in biotech and expertise in both science and business, Antony Blanc brings together the skills we need to lead our increasingly important presence in Switzerland," said Synosia Chief Executive Officer and President Dr. Ian Massey. "Our three pharmaceutical partners are based in Basel and this appointment will give us the leadership we need in Europe to meet our ambitious goals for 2008, including the start of four phase II trials."

"Synosia has a broad clinical-stage portfolio with several advanced molecules, highly experienced leaders, a well-aligned and strong investor base and a grounding in both the US and in Switzerland. I look forward to building on this promising combination to create a leading CNS-focused specialty pharma company" said Blanc.

Antony Blanc replaces Herve Girsault M.B.A., who will remain on Synosia's board of directors and continue to act as a key business advisor to the company.

About Synosia Therapeutics

Synosia Therapeutics develops and intends to commercialize innovative and clinically differentiated products for unmet medical needs in psychiatry and neurology. The privately-owned company is developing six clinical-stage compounds acquired through key partnerships with Novartis, Roche and Syngenta, including two marketed drugs that will be tested in new indications, extending their reach
'/>"/>

SOURCE Synosia Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...the Practical Implementation of ... October 13 /- After the successful,s...ram at the beginning of,the year, Ziehm Imaging, p...consequently expanding its training offer. The Zie...ional standards, in order to keep its,partners up ...
(Date:10/13/2008)... 13 /-,Following fulfillmen...,completed the acquisition* of all outstanding sha...escription optical equipment., Satisloh designs a...ing,machines, as well as consumables, for prescrip...evenue in 2007 and employs more than 400 people,ar...
(Date:10/11/2008)...ire/ -- MedImmune announced today it,will present ...cs (AAP),2008 National Conference & Exhibition tha...to the prevention of respiratory syncytial virus (...on among preterm infants., "As we gain data that ...reterm babies, the benefits of preventive care bec...
(Date:10/10/2008)...swire-FirstCall/ -- Neurobiological,Technologies, ... will hold a,conference call on Monday, October 13...) Phase 3 Trial Program for acute ischemic stroke....nt and chief executive,officer and Warren W. Wasie...October 13, 2008 -- Time: 1:00 p.m. (ET), 12:00 ...
Breaking Biology Technology:Ziehm Imaging Extends its Training Offer 2Ziehm Imaging Extends its Training Offer 3Ziehm Imaging Extends its Training Offer 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 2MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 3MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 5Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2
...ill assume duties as director of the state Depart...merce Secretary Cory Nettles announced the hire ...initiative. , ,Part of the key to our successful ...ty really lie in collaborative efforts. We hope to...sted in starting technology businesses to the righ...
...e it, not all technologists are the life of the pa...r respective fields and even visionary in how they... and networking isnt often their strength. In fact...How do you know when two techies are talking? They...was no time for shoe-staring at Connections: Chip...
...Gov. Jim Doyle took office last year he faced the ... a gap of nearly 3.2 billion dollars and a challe...vernor. , ,However, at the 2004 Governors Confere...ssed a crowd of industry and civic representatives...industry has helped raise the state beyond its tro...
... is a nation deeply imbued with Confucian values, ... from ancestors and should never be tampered with....l last week when South Korean researchers announce...an embryo and then collect from it master stem ce...w their own replacement tissues. , ,For every Sout...
Other Biology Technology:Nettles Names Christenson as Director of Bureau of Entrepreneurship 2Pushing the Fast-Forward Button on Networking Does It Work? 2Doyle Preaches Importance of Tech Industry at Summit 2How Wisconsin Can Maintain Its Lead in Stem Cell Research 2How Wisconsin Can Maintain Its Lead in Stem Cell Research 3
(Date:10/12/2008)...ogy journal (October 12th) reveals how scientists...t UCL are using a novel nanomechanical approach to...e few antibiotics that can be used to combat incre...earchers, led by Dr Rachel McKendry and Professor ...apable of providing new insight into how antibioti...
(Date:10/10/2008)... world,s top scientists and clinicians in the huma...resent their latest research findings at the 58th ...enetics (ASHG) from Tuesday, November 11, through ...Convention Center., Founded in 1948, ASHG is the ...uman genetics,specialists worldwide, representing...
(Date:10/10/2008)...Governor Jim Doyle today announced a historic coll...ions to advance personalized health care leading t... The Wisconsin Genomics Initiative is a collaborat...edical College of Wisconsin (MCW), University of W...MPH) and UW-Milwaukee (UWM). , Wisconsin is a le...
(Date:10/10/2008)...l, will be the focus of the Society for Nutrition ...e event is just one small step in fighting world h... the world and requires immediate attention in ord..., hunger and deficiencies. The Society for Nutriti...public to get involved and make a difference in th...
Breaking Biology News(10 mins):Nanotechnology boosts war on superbugs 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 4The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 5Governor Doyle announces historic genomic research collaboration 2World Food Day brings attention to food security around the globe 2Rigel to Present at BIO CEO 26 Investor Conference 3058 1Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 1Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 2Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 3Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results 3057 1Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results 3057 2Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 1Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 2Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 3
...y comparing 140 sequenced bacterial genomes, resea...s essential to bacterial replication ?and they did.... , Mikhail Gelfand, a Howard Hughes Medical Inst...ute for Information Transmission Problems (IITP) i...onov, used comparative genomics to identify a new ...
... first-of-its-kind multi-center trial has shown th...hildren who suffered traumatic brain injury. , The... Pittsburgh neurosurgeon P. David Adelson, MD, and...te hypothermia initiated after severe traumatic br...n for children. , TBI initiates several metabolic...
...he 2004-2005 flu season was at least as severe as ...o data from Solucient, a leading provider of healt...ted the most recent flu season from being even wor...ital admissions for community-acquired pneumonia (...flu. Solucient analyzed CAP discharge data from Oc...
...esearch into a new treatment for nerve damage caus...iabetic patients, say experts. , The treatment mi...and feet if early effects on nerve protection and ...e in diabetes is the major cause of non-traumatic .... , Scientists at The University of Manchester, wo...
Other Biology News:Bioinformatics reveals new gene regulation system 2Bioinformatics reveals new gene regulation system 3Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids 2Diabetic nerve therapy shows 'striking' results 2
Lingo-1 (K-13)
HIF-1 beta (ARNT1) Purified Anti-Mouse, Anti-Rat, Anti-Human clone 29, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details.
MOUSE ANTI PORCINE SLA 1:FITC Immunogen: Porcine peripheral blood mononuclear cells.
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF.
Biology Products: